Ken Griffin Sop Hi A Genetics Sa Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Citadel Advisors LLC holds 5,900 shares of SOPH stock, worth $19,293. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,900Holding current value
$19,293% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding SOPH
# of Institutions
36Shares Held
20.1MCall Options Held
5.9KPut Options Held
300-
Generation Investment Management LLP London, X06.79MShares$22.2 Million0.12% of portfolio
-
Banque Pictet & Cie Sa2.24MShares$7.34 Million0.06% of portfolio
-
Chuck Akre Akre Capital Management LLC | Middleburg, Va2.24MShares$7.32 Million0.07% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.22MShares$7.26 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V82.17MShares$7.09 Million0.01% of portfolio
About SOPHiA GENETICS SA
- Ticker SOPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 64,153,700
- Market Cap $210M
- Description
- SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...